741287-75-2 Usage
Uses
Used in Pharmaceutical Industry:
2,5-Piperazinedione,1,3,3-trimethyl-(9CI) is used as a pharmaceutical intermediate for the synthesis of various organic compounds. Its unique molecular structure and properties make it a valuable building block in the development of new drugs and therapeutic agents.
Used in Anticancer Applications:
2,5-Piperazinedione,1,3,3-trimethyl-(9CI) is used as a potential anticancer agent due to its antitumor properties. Research has shown that 2,5-Piperazinedione,1,3,3-trimethyl-(9CI) may have the ability to inhibit the growth and progression of cancer cells, making it a promising candidate for further investigation and development in the field of oncology.
Used in Drug Development:
2,5-Piperazinedione,1,3,3-trimethyl-(9CI) is used as a key component in the development of new therapeutic drugs. Its potential applications in medicinal chemistry and pharmaceutical research highlight its importance in the discovery and creation of novel treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 741287-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,1,2,8 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 741287-75:
(8*7)+(7*4)+(6*1)+(5*2)+(4*8)+(3*7)+(2*7)+(1*5)=172
172 % 10 = 2
So 741287-75-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H12N2O2/c1-7(2)6(11)9(3)4-5(10)8-7/h4H2,1-3H3,(H,8,10)
741287-75-2Relevant academic research and scientific papers
FIVE-MEMBERED HETEROCYCLIC DERIVATIVE
-
Page/Page column 31, (2010/11/08)
The present invention relates to a compound represented by formula (I): a salt of the compound, or a solvate of the compound or the salt; a drug containing any of the compounds, the salts, and the solvates; a preventive and/or therapeutic agent for an ischemic disease containing any of the compounds, the salts, and the solvates; and a platelet coagulation inhibitor containing any of the compounds, the salts, and the solvates. The compound of the present invention is useful as a strong platelet coagulation inhibitor without inhibiting COX-1 or COX-2.
